|
4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt Suppliers list
|
|
| | 4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt Basic information |
| Product Name: | 4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt | | Synonyms: | 4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt;Danoprevir sodium salt;Danoprevir (Na);4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsul;4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a;FJEYRHUWXZLIGS-NMSJDDSISA-N;Danoprevir sodium | | CAS: | 916826-48-7 | | MF: | C35H47FN5NaO9S | | MW: | 755.84 | | EINECS: | | | Product Categories: | | | Mol File: | 916826-48-7.mol | ![4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt Structure](CAS/20211123/GIF/916826-48-7.gif) |
| | 4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt Chemical Properties |
| | 4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt Usage And Synthesis |
| Uses | Danoprevir (sodium) (ITMN-191) is a compound used to inhibit hepatitis C virus infection. | | References | [1] Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy DOI:10.2147/DDDT.S254754 |
| | 4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt Preparation Products And Raw materials |
|